Passero V - Search Results

1

Veterans Health Administration National TeleOncology Service.

Zullig LL, Raska W, McWhirter G, Sherman SE, Makarov D, Becker D, King HA, Pura J, Jeffreys AS, Danus S, Passero V, Goldstein KM, Kelley MJ. Zullig LL, et al. Among authors: passero v. JCO Oncol Pract. 2023 Apr;19(4):e504-e510. doi: 10.1200/OP.22.00455. Epub 2023 Jan 17. JCO Oncol Pract. 2023. PMID: 36649579 Free PMC article.

2

Use of targeted therapies for advanced renal cell carcinoma in the Veterans Health Administration.

Aspinall SL, Zhao X, Geraci MC, Good CB, Cunningham FE, Heron BB, Becker D, Lee S, Prasad V; Targeted Therapies in Veterans with RCC Study Group. Aspinall SL, et al. Cancer Med. 2019 Nov;8(15):6651-6661. doi: 10.1002/cam4.2531. Epub 2019 Sep 19. Cancer Med. 2019. PMID: 31536684 Free PMC article.

3

Telehealth for Cancer Care in Veterans: Opportunities and Challenges Revealed by COVID.

Jiang CY, El-Kouri NT, Elliot D, Shields J, Caram MEV, Frankel TL, Ramnath N, Passero VA. Jiang CY, et al. Among authors: passero va. JCO Oncol Pract. 2021 Jan;17(1):22-29. doi: 10.1200/OP.20.00520. Epub 2020 Sep 24. JCO Oncol Pract. 2021. PMID: 32970512

4

Developing national cancer survivorship standards to inform quality of care in the United States using a consensus approach.

Mollica MA, McWhirter G, Tonorezos E, Fenderson J, Freyer DR, Jefford M, Luevano CJ, Mullett T, Nasso SF, Schilling E, Passero VA; National Cancer Survivorship Standards Subject Matter Expert Group. Mollica MA, et al. Among authors: passero va. J Cancer Surviv. 2024 May 13. doi: 10.1007/s11764-024-01602-6. Online ahead of print. J Cancer Surviv. 2024. PMID: 38739299

5

Cost-Effectiveness Analysis of Adjuvant Stage III Colon Cancer Treatment at Veterans Affairs Medical Centers.

Soni A, Aspinall SL, Zhao X, Good CB, Cunningham FE, Chatta G, Passero V, Smith KJ. Soni A, et al. Among authors: passero v. Oncol Res. 2014;22(5-6):311-9. doi: 10.3727/096504015X14424348426152. Oncol Res. 2014. PMID: 26629943 Free PMC article.

6

VHA Practice Guideline Recommendations for Diffuse Gliomas.

Kulich S, Becker D, Dacic S, Duvvuri U, Ehsan A, Gutkin D, Hou P, Icardi M, Lyle P, Lynch J, Montgomery B, Passero V, Przygodzki R, Colman H. Kulich S, et al. Among authors: passero v. Fed Pract. 2018 Aug;35(Suppl 5):S28-S35. Fed Pract. 2018. PMID: 30766402 Free PMC article.

7

Erratum to: Modified Atkins diet in advanced malignancies-final results of a safety and feasibility trial within the Veterans Affairs Pittsburgh Healthcare System.

Tan-Shalaby JL, Carrick J, Edinger K, Genovese D, Liman AD, Passero VA, Shah RB. Tan-Shalaby JL, et al. Nutr Metab (Lond). 2016 Sep 1;13(1):61. doi: 10.1186/s12986-016-0120-z. eCollection 2016. Nutr Metab (Lond). 2016. PMID: 27594893 Free PMC article.

8

Impact of the COVID-19 pandemic on new starts to oral oncology medications in the US.

Neilson L, Kohli M, Munshi KD, K Peasah S, Henderson R, Passero V, Good CB. Neilson L, et al. Among authors: passero v. J Oncol Pharm Pract. 2023 Mar;29(2):370-374. doi: 10.1177/10781552211073778. Epub 2022 Jan 11. J Oncol Pharm Pract. 2023. PMID: 35014888 Free PMC article.

9

Dispensing and Monitoring Oral Anticancer Therapy.

Shields JL, Englert B, Passero VA. Shields JL, et al. Fed Pract. 2015 Jan;32(Suppl 1):38S-41S. Fed Pract. 2015. PMID: 30766093 Free PMC article.

10

Modified Atkins diet in advanced malignancies - final results of a safety and feasibility trial within the Veterans Affairs Pittsburgh Healthcare System.

Tan-Shalaby JL, Carrick J, Edinger K, Genovese D, Liman AD, Passero VA, Shah RB. Tan-Shalaby JL, et al. Nutr Metab (Lond). 2016 Aug 12;13:52. doi: 10.1186/s12986-016-0113-y. eCollection 2016. Nutr Metab (Lond). 2016. PMID: 27525031 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page